Publications
Specialty
Search
Oncology
05/15/2024
At the Great Debates and Updates in Lung Cancer Meeting in New York, New York, Corey Langer, MD, argued that antibody drug conjugates are not ready to replace TROP-2 inhibitors as the standard of care for patients with lung cancers.
Psych Congress Network
05/15/2024
At the end of April, Neurocrine Biosciences, Inc. announced the approval of INGREZZA® SPRINKLE (valbenazine) capsules by the FDA. This approval provides an alternative option for patients with dysphagia or who have difficulty swallowing.
Pharmacy Learning Network
05/15/2024
Reports of defective containers have prompted FDC Limited to recall 4 lots of timolol maleate ophthalmic solution distributed in New Jersey.
Pharmacy Learning Network
05/15/2024
Sun Pharmaceutical Industries Inc. is recalling 11,016 vials of amphotericin B liposome for injection because assay results were out of specification.
Pharmacy Learning Network
05/15/2024
A Class I recall has been issued for 6 lots of potentially subpotent sapropterin dihydrochloride powder for oral solution distributed throughout the United States.
EMSWorld
05/15/2024
The Michigan Department of Health and Human Services has funded a statewide EMS workforce training grant program for 2023 to make EMS education and training more accessible.
EMSWorld
05/15/2024
A collaboration between private and public entities was announced today at the National Association of State EMS Officials annual conference that will help reduce deaths and serious injuries as well as prevent transportation-related motor vehicle crashes (MVC) on the nation’s highway system.
First Report Managed Care
05/15/2024
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
EP Lab Digest
05/15/2024
ST.
The Dermatologist
05/15/2024
Researchers aimed to develop a 3-dimensional model of neural invasion in squamous cell carcinoma to better understand its underlying biologic mechanisms, which are still poorly understood.
Wounds, Wound Care
05/15/2024
Linda L Benskin, PhD, RN, SRN (Ghana), CWCN, CWS, DAPWCA, and Richard Benskin share background and key findings from their original research paper, "Development of the Available Technology Dressing: An Evidence-Based, Sustainable Solution for Wound Management in Low-Resource Settings."
Cath Lab Digest, Vascular Disease Management, Journal of Invasive Cardiology, CardioVascular
05/15/2024
This project aims to develop a multi-sensing device that can be implanted into blood vessels, such as peripheral veins or arteries, to monitor various body parameters and the overall health status of individuals.
Psych Congress Network, Psychiatry & Behavioral Health
05/15/2024
Though the number of buprenorphine prescribers increased following the elimination of the X waiver in January 2023, the total number of patients using the medication to manage opioid use disorder (OUD) “changed little.”
EP Lab Digest
05/15/2024
Analysis conducted on a hierarchical endpoint comprised of mortality, HF hospitalization, and health status shows that patients treated with phrenic nerve stimulation may be nearly five times as likely to experience a clinical benefit compared to those in the control group
EP Lab Digest
05/15/2024
Empowering healthcare partners to streamline the delivery of cardiac monitoring services on an integrated technology solution
EP Lab Digest
05/15/2024
Atraverse Medical, a San Diego-based medical device company, today announces the FDA clearance of its HOTWIRE™ radiofrequency (RF) guidewire, a novel device that enables zero exchange left-heart access while also acting as a rail for catheter-based therapy systems.
EP Lab Digest
05/15/2024
Data Demonstrates vMap’s Ability to Locate Arrhythmia Sources and Deliver Critical Value
Journal of Clinical Pathways
05/15/2024
A systematic literature review summarizes the economic and health-related quality of life (HRQoL) outcomes experienced by patients with early-stage hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative (HR+/HER2−) breast cancer.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
05/15/2024
A new study demonstrated parity between a minimally invasive procedure to replace the aortic valve in the heart—transcatheter aortic valve replacement (TAVR)—and surgical aortic valve replacement (SAVR).